Carl Stubbings

Carl Stubbings has extensive work experience in the biotechnology and diagnostics industry. Carl has held various executive positions and non-executive director roles in multiple companies.

Most recently, they worked as a Non Executive Director at InGeNA since October 2023. Prior to that, they served as the Chief Commercial Officer at Genetic Technologies Limited, and also held a Non Executive Director position at Sangui Bio.

From 2020 to 2021, Carl was the Chief Operating Officer at BARD1 Life Sciences Ltd.

Carl has also served as the Chief Executive Officer & Managing Director at Sienna Cancer Diagnostics from 2019 to 2020, and as the Chief Executive Officer at BCAL Diagnostics for a brief period in 2019.

Earlier in their career, they worked as a Commercialisation Lead at Minomic International Ltd, a Non Executive Director at Analytica Ltd and Otakaro Pathways, and as the Chief Business Officer at Benitec Biopharma.

Carl Stubbings has a strong background in business development and leadership roles in the biotech industry.

Carl Stubbings attended QUT (Queensland University of Technology) from 1974 to 1978, where they pursued a Bachelor of Applied Science in Medical Technology with a focus on Microbiology. Prior to that, they attended Cavendish Road State High School, but no specific degree or field of study is mentioned for this period.